Literature DB >> 21570386

Urinary calcium response to high dose vitamin D3 with calcium supplementation in patients with multiple sclerosis.

Samantha M Kimball1, Jodie M Burton, Paul G O'Connor, Reinhold Vieth.   

Abstract

OBJECTIVE: To characterize the effect of vitamin D(3) intake on urinary calcium:creatinine ratios across predefined ranges of serum 25(OH)D.
DESIGN: Patients with multiple sclerosis (n=25) received escalating doses of vitamin D(3) (4000-40,000IU/d) with calcium (1200mg/d).
RESULTS: Urinary calcium:creatinine was driven by increased 25(OH)D when concentrations were <75nmol/L (r=0.424, p=0.009) and >200nmol/L (r=0.281, p=0.01), but no relationship existed when 25(OH)D concentrations were 76-200nmol/L.
CONCLUSIONS: A "safe", physiological range of 25(OH)D concentrations is 75-200nmol/L.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570386     DOI: 10.1016/j.clinbiochem.2011.04.017

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Vitamin D and parameters of calcium homeostasis in inpatients with and without Type 2 diabetes mellitus.

Authors:  V Carnevale; M Inglese; M A Annese; A De Matthaeis; S A Santini; V Frusciante; A Fontana; M Copetti; F Pellegrini; G D'Amico
Journal:  J Endocrinol Invest       Date:  2012-01-30       Impact factor: 4.256

2.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

3.  Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report.

Authors:  Barbara M van Amerongen; François Feron
Journal:  Int J Mol Sci       Date:  2012-10-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.